![Europe / Science / Innovative Medicines Initiative / Science and technology in Europe / European Federation of Pharmaceutical Industries and Associations / Drug discovery / Framework Programmes for Research and Technological Development / Alternative medicine / Clinical trial / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology Europe / Science / Innovative Medicines Initiative / Science and technology in Europe / European Federation of Pharmaceutical Industries and Associations / Drug discovery / Framework Programmes for Research and Technological Development / Alternative medicine / Clinical trial / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology](https://www.pdfsearch.io/img/cd8239d3cc8c53f434398003259b2d4b.jpg)
| Document Date: 2015-01-15 11:59:46 Open Document File Size: 315,60 KBShare Result on Facebook
City Ingelheim / Brussels / / Company Lundbeck / Eli Lilly / Pfizer / Bayer / Novartis / Sanofi / Amgen / EFPIA Research Directors Group / Merck KGaA / AstraZeneca / Novo Nordisk / / Continent Europe / / Country United Kingdom / / Currency EUR / / / Facility Massachusetts Institute of Technology / / / IndustryTerm pharmaceutical industry / pragmatic and viable solutions / healthcare delivery challenges / biomedical imaging / healthcare delivery / knowledge management / health technology assessment / pharmaceutical legislation / healthcare providers / medical information technology / medicinal products / / MedicalCondition diseases / / OperatingSystem Scope / / Organization World Health Organisation / European Commission / FDA / Food Safety / Massachusetts Institute of Technology / European Union / / / Position Governor / / ProvinceOrState Massachusetts / / Technology knowledge management / medical information technology / drug development / / URL www.imi.europa.eu / http /
SocialTag |